BAY59-8862

BAY59-8862 · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY59-8862, covering 2014-12-23 to 2014-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients [Phase 2]